The endocannabinoid noladin ether acts as a full agonist at human CB2 cannabinoid receptors
about
Phase I hydroxylated metabolites of the K2 synthetic cannabinoid JWH-018 retain in vitro and in vivo cannabinoid 1 receptor affinity and activityThe CB2 cannabinoid agonist AM-1241 prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis when initiated at symptom onsetWhat we know and do not know about the cannabinoid receptor 2 (CB2)AM-251 and rimonabant act as direct antagonists at mu-opioid receptors: implications for opioid/cannabinoid interaction studiesTamoxifen Isomers and Metabolites Exhibit Distinct Affinity and Activity at Cannabinoid Receptors: Potential Scaffold for Drug DevelopmentDesign, synthesis, and biological evaluation of aminoalkylindole derivatives as cannabinoid receptor ligands with potential for treatment of alcohol abuse.In vivo effects of CB2 receptor-selective cannabinoids on the vasculature of normal and arthritic rat knee joints.CB2: a cannabinoid receptor with an identity crisisAnti-proliferative effect of a putative endocannabinoid, 2-arachidonylglyceryl ether in prostate carcinoma cells.Monohydroxylated metabolites of the K2 synthetic cannabinoid JWH-073 retain intermediate to high cannabinoid 1 receptor (CB1R) affinity and exhibit neutral antagonist to partial agonist activity.Non-Selective Cannabinoid Receptor Antagonists, Hinokiresinols Reduce Infiltration of Microglia/Macrophages into Ischemic Brain Lesions in Rat via Modulating 2-Arachidonolyglycerol-Induced Migration and Mitochondrial Activity.Cytochrome P450-mediated oxidative metabolism of abused synthetic cannabinoids found in K2/Spice: identification of novel cannabinoid receptor ligands.Targeting cannabinoid receptor CB(2) in cardiovascular disorders: promises and controversies.Repeated administration of phytocannabinoid Δ(9)-THC or synthetic cannabinoids JWH-018 and JWH-073 induces tolerance to hypothermia but not locomotor suppression in mice, and reduces CB1 receptor expression and function in a brain region-specific maDirect suppression of autoreactive lymphocytes in the central nervous system via the CB2 receptorNatural prenylated resveratrol analogs arachidin-1 and -3 demonstrate improved glucuronidation profiles and have affinity for cannabinoid receptors.Endocannabinoid regulation of matrix metalloproteinases: implications in ischemic stroke.Human metabolites of synthetic cannabinoids JWH-018 and JWH-073 bind with high affinity and act as potent agonists at cannabinoid type-2 receptors.Betulinic acid targets YY1 and ErbB2 through cannabinoid receptor-dependent disruption of microRNA-27a:ZBTB10 in breast cancer.The Structure-Function Relationships of Classical Cannabinoids: CB1/CB2 Modulation.2-Arachidonoyl-glycerol- and arachidonic acid-stimulated neutrophils release antimicrobial effectors against E. coli, S. aureus, HSV-1, and RSV.CB1 and CB2 receptors are novel molecular targets for Tamoxifen and 4OH-Tamoxifen.Selective Estrogen Receptor Modulators: Cannabinoid Receptor Inverse Agonists with Differential CB1 and CB2 Selectivity.Fatty acid amide signaling molecules.The effect of endocannabinoid system in ischemia-reperfusion injury: a friend or a foe?Detection of cannabinoid receptors CB1 and CB2 within basal ganglia output neurons in macaques: changes following experimental parkinsonismAntinociceptive effects of the 6-O-sulfate ester of morphine in normal and diabetic rats: Comparative role of mu- and delta-opioid receptors.Characterization of the intrinsic activity for a novel class of cannabinoid receptor ligands: Indole quinuclidine analogs.Hydroxyalkylation with cyclic sulfates: synthesis of carbazole derived CB(2) ligands with increased polarity.Cannabis and Pediatric Inflammatory Bowel Disease: Change Blossoms a Mile High.
P2860
Q21135310-51192973-7168-4C5D-8B89-E5869CB73401Q24650098-6425D7FB-AF3A-4283-9D4D-0609300D9DB6Q27686851-E0A41FC1-AD1A-4167-8917-7ABC656F9511Q28270589-A246EAB6-E075-4A13-821A-0DD6D5634B1FQ28554883-144B89D9-24A1-4257-8E46-0BE13AB6648FQ30569742-6EB44CA6-1B3C-41A9-9DCA-0CE3DF00E0F9Q33304983-8E96D0E6-65C1-474B-9F40-DA13AD12692CQ34098185-FFEC18DE-72E5-45A3-B8A7-3D2B670BECF9Q34575446-1621B531-F34E-4CFE-A02F-6FD5EE541914Q35785005-A2349E40-51B2-4CBD-A97B-60123658EA04Q35827422-4D83D89B-4F7D-47BE-A557-DC26D88616D8Q36335446-714FF506-F2F6-45C0-9FFD-B75403A0F55EQ36346915-928D3B8B-67AC-4D6A-B368-B0A7930EC63CQ36385137-CB0F6B75-BF15-4076-8E09-7DC4F37C4F0FQ36416340-D215892F-0327-46A7-A6C6-4B696E0F2705Q36717019-4F02B597-A015-4290-8752-617628612002Q36802414-E54B23D4-2764-467F-BFAC-73D415FBA206Q36938493-C0F31049-8800-4C3A-AE41-616CEDF55075Q37046302-947B6D0D-3195-4B8B-9635-9242314A10FDQ37052244-B25A1DC4-918A-4BD4-A438-ED23D08111D2Q37198046-11311E37-84AB-47DD-BF3C-5DB95A84382EQ37386840-0646DA3E-9443-4AAE-B4F8-624C6D1BB38FQ37525458-9A354541-EAD2-4CDA-959F-7DF12BBFA790Q37785382-5EF7582A-2923-4B8B-8419-DF2BF5155C9EQ38455748-4FDECA9E-72D7-4434-A68E-7E470E328D27Q42095959-4D2F9147-77B5-4B16-AE64-5840326966A0Q42742832-A722E40F-DEF3-4D6B-BC78-867CF4E3EF6AQ43214296-9B0FE6AA-5386-4D6B-BF62-0A287F937F66Q51751156-7C028A7A-F499-400A-9EE0-29E80E047DF6Q55090140-AAD375A8-9AF5-4829-AA5E-98D24BB2563E
P2860
The endocannabinoid noladin ether acts as a full agonist at human CB2 cannabinoid receptors
description
2005 nî lūn-bûn
@nan
2005 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
The endocannabinoid noladin et ...... uman CB2 cannabinoid receptors
@ast
The endocannabinoid noladin et ...... uman CB2 cannabinoid receptors
@en
The endocannabinoid noladin et ...... uman CB2 cannabinoid receptors
@nl
type
label
The endocannabinoid noladin et ...... uman CB2 cannabinoid receptors
@ast
The endocannabinoid noladin et ...... uman CB2 cannabinoid receptors
@en
The endocannabinoid noladin et ...... uman CB2 cannabinoid receptors
@nl
prefLabel
The endocannabinoid noladin et ...... uman CB2 cannabinoid receptors
@ast
The endocannabinoid noladin et ...... uman CB2 cannabinoid receptors
@en
The endocannabinoid noladin et ...... uman CB2 cannabinoid receptors
@nl
P2093
P921
P3181
P356
P1476
The endocannabinoid noladin et ...... uman CB2 cannabinoid receptors
@en
P2093
Biny K Joseph
Jennifer L Shoemaker
Michael B Ruckle
Paul L Prather
Philip R Mayeux
P304
P3181
P356
10.1124/JPET.105.085282
P407
P577
2005-08-01T00:00:00Z